MA27879A1 - Derives de tetrahydrocarbazole et leur utilisation pharmaceutique - Google Patents
Derives de tetrahydrocarbazole et leur utilisation pharmaceutiqueInfo
- Publication number
- MA27879A1 MA27879A1 MA28645A MA28645A MA27879A1 MA 27879 A1 MA27879 A1 MA 27879A1 MA 28645 A MA28645 A MA 28645A MA 28645 A MA28645 A MA 28645A MA 27879 A1 MA27879 A1 MA 27879A1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical use
- tetrahydrocarbazole derivatives
- tetrahydrocarbazole
- derivatives
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47797203P | 2003-06-12 | 2003-06-12 | |
| US49778703P | 2003-08-26 | 2003-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27879A1 true MA27879A1 (fr) | 2006-05-02 |
Family
ID=34068099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28645A MA27879A1 (fr) | 2003-06-12 | 2005-12-09 | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7419997B2 (fr) |
| EP (1) | EP1646610B1 (fr) |
| JP (1) | JP2007500750A (fr) |
| KR (1) | KR20060017544A (fr) |
| AU (1) | AU2004256052A1 (fr) |
| BR (1) | BRPI0411245A (fr) |
| CA (1) | CA2528336A1 (fr) |
| CO (1) | CO5660264A2 (fr) |
| DE (1) | DE602004022169D1 (fr) |
| ES (1) | ES2327416T3 (fr) |
| IL (1) | IL172087A0 (fr) |
| MA (1) | MA27879A1 (fr) |
| NO (1) | NO20055750L (fr) |
| RU (1) | RU2005138126A (fr) |
| WO (1) | WO2005005386A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1678137A1 (fr) * | 2003-10-15 | 2006-07-12 | Chiron Corporation | Compositions et procedes d inhibition virale |
| CN102408425A (zh) | 2004-03-15 | 2012-04-11 | Ptc医疗公司 | 用于抑制血管生成的咔啉衍生物及其应用 |
| US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
| US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
| US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
| WO2006012310A2 (fr) * | 2004-06-25 | 2006-02-02 | Genzyme Corporation | Derives de carbazole pour le traitement de la polykystose renale |
| US20090170906A1 (en) * | 2004-11-22 | 2009-07-02 | Kristjan Gudmundsson | Hcv inhibitors |
| US8143257B2 (en) * | 2004-11-23 | 2012-03-27 | Ptc Therapeutics, Inc. | Substituted phenols as active agents inhibiting VEGF production |
| US11458121B2 (en) * | 2017-06-26 | 2022-10-04 | Rutgers, The State University Of New Jersey | Therapeutic compounds and methods to treat infection |
| US10882821B1 (en) | 2017-09-26 | 2021-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9008108D0 (en) * | 1990-04-10 | 1990-06-06 | Bayer Ag | Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles |
| US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
| GB0015904D0 (en) | 2000-06-28 | 2000-08-23 | Hoffmann La Roche | Inhibitors of HPV E1 helicase enzyme |
| DE10164564B4 (de) * | 2001-12-14 | 2007-05-16 | Zentaris Gmbh | Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR) |
-
2004
- 2004-06-07 RU RU2005138126/04A patent/RU2005138126A/ru not_active Application Discontinuation
- 2004-06-07 KR KR1020057023780A patent/KR20060017544A/ko not_active Application Discontinuation
- 2004-06-07 US US10/560,016 patent/US7419997B2/en not_active Expired - Fee Related
- 2004-06-07 WO PCT/US2004/018180 patent/WO2005005386A1/fr active Application Filing
- 2004-06-07 CA CA002528336A patent/CA2528336A1/fr not_active Abandoned
- 2004-06-07 JP JP2006533613A patent/JP2007500750A/ja active Pending
- 2004-06-07 EP EP04776370A patent/EP1646610B1/fr not_active Expired - Lifetime
- 2004-06-07 BR BRPI0411245-8A patent/BRPI0411245A/pt not_active IP Right Cessation
- 2004-06-07 ES ES04776370T patent/ES2327416T3/es not_active Expired - Lifetime
- 2004-06-07 AU AU2004256052A patent/AU2004256052A1/en not_active Abandoned
- 2004-06-07 DE DE602004022169T patent/DE602004022169D1/de not_active Expired - Lifetime
-
2005
- 2005-11-21 IL IL172087A patent/IL172087A0/en unknown
- 2005-12-05 NO NO20055750A patent/NO20055750L/no not_active Application Discontinuation
- 2005-12-09 MA MA28645A patent/MA27879A1/fr unknown
- 2005-12-15 CO CO05126691A patent/CO5660264A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004022169D1 (de) | 2009-09-03 |
| EP1646610B1 (fr) | 2009-07-22 |
| NO20055750D0 (no) | 2005-12-05 |
| AU2004256052A1 (en) | 2005-01-20 |
| JP2007500750A (ja) | 2007-01-18 |
| BRPI0411245A (pt) | 2006-07-18 |
| US7419997B2 (en) | 2008-09-02 |
| EP1646610A1 (fr) | 2006-04-19 |
| KR20060017544A (ko) | 2006-02-23 |
| US20060148857A1 (en) | 2006-07-06 |
| IL172087A0 (en) | 2009-02-11 |
| CO5660264A2 (es) | 2006-07-31 |
| WO2005005386A1 (fr) | 2005-01-20 |
| CA2528336A1 (fr) | 2005-01-20 |
| ES2327416T3 (es) | 2009-10-29 |
| RU2005138126A (ru) | 2006-07-27 |
| NO20055750L (no) | 2006-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27879A1 (fr) | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique | |
| NO20054681D0 (no) | Farmasoytiske produkter | |
| NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
| CY2017048I1 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
| DE502004004205D1 (de) | Gegen missbrauch gesicherte darreichungsform | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
| ATE381335T1 (de) | 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung | |
| DE602004016967D1 (de) | Flüssige pharmazeutische palonosetronformulierungen | |
| IS7571A (is) | Ný lífeðlisfræðilega virk efni | |
| DK1425019T3 (da) | Farmaceutisk sammensætning omfattende et androgen | |
| DK1200092T3 (da) | Beta-carbolin-lægemiddelprodukter | |
| NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
| FR2862967B1 (fr) | Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique | |
| DK1750765T3 (da) | Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel | |
| DE10393889D2 (de) | Medikament-Dosimeter-Kombipackung | |
| DE502004007948D1 (de) | Uildersystem und schmutzablösevermögendem cellulosederivat | |
| DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
| FR2861072B1 (fr) | Derives de cyclopropylmethanones, leur preparation et leur utilisation en therapeutique | |
| FI20040148A (fi) | Lääkeannos- tai lääkevalmistetunnistin | |
| SE0300665L (sv) | Förfarande och anordning vid drogtest | |
| UA7161S (uk) | Піктограма фармацевтичного засобу | |
| UA7037S (uk) | Піктограма фармацевтичного засобу | |
| UA7159S (uk) | Піктограма фармацевтичного засобу | |
| UA7158S (uk) | Піктограма фармацевтичного засобу |